Getein Biotech, Inc (603387.SS)
CNY 7.94
(1.4%)
CNY 7.94
(1.4%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 229.7 Million CNY | -14.73% |
| 2022 | 269.38 Million CNY | 6.77% |
| 2021 | 252.3 Million CNY | 19.02% |
| 2020 | 211.98 Million CNY | 31.93% |
| 2019 | 160.68 Million CNY | 27.15% |
| 2018 | 126.37 Million CNY | 102.87% |
| 2017 | 62.29 Million CNY | 26.99% |
| 2016 | 49.05 Million CNY | 24.59% |
| 2015 | 39.37 Million CNY | 95.06% |
| 2014 | 20.18 Million CNY | 44.66% |
| 2013 | 13.95 Million CNY | 19.27% |
| 2012 | 11.69 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 226.54 Million CNY | -1.37% |
| 2024 Q3 | 224.58 Million CNY | -0.63% |
| 2024 Q2 | 225.99 Million CNY | -0.24% |
| 2023 Q1 | 324.11 Million CNY | 20.32% |
| 2023 FY | 229.7 Million CNY | -14.73% |
| 2023 Q3 | 273.07 Million CNY | 1.1% |
| 2023 Q2 | 270.09 Million CNY | -16.67% |
| 2023 Q4 | 229.7 Million CNY | -15.88% |
| 2022 Q3 | 376.11 Million CNY | 9.26% |
| 2022 Q2 | 344.22 Million CNY | -0.33% |
| 2022 FY | 269.38 Million CNY | 6.77% |
| 2022 Q1 | 345.35 Million CNY | 36.88% |
| 2022 Q4 | 269.38 Million CNY | -28.38% |
| 2021 Q3 | 246.61 Million CNY | 2.5% |
| 2021 Q2 | 240.58 Million CNY | 7.79% |
| 2021 Q1 | 223.19 Million CNY | 5.28% |
| 2021 Q4 | 252.3 Million CNY | 2.31% |
| 2021 FY | 252.3 Million CNY | 19.02% |
| 2020 Q1 | 190.42 Million CNY | 18.51% |
| 2020 Q2 | 216.66 Million CNY | 13.78% |
| 2020 Q4 | 211.98 Million CNY | -3.38% |
| 2020 Q3 | 219.39 Million CNY | 1.26% |
| 2020 FY | 211.98 Million CNY | 31.93% |
| 2019 Q2 | 146.26 Million CNY | 10.99% |
| 2019 FY | 160.68 Million CNY | 27.15% |
| 2019 Q4 | 160.68 Million CNY | -3.14% |
| 2019 Q3 | 165.88 Million CNY | 13.41% |
| 2019 Q1 | 131.78 Million CNY | 4.28% |
| 2018 Q3 | 116.39 Million CNY | 23.44% |
| 2018 FY | 126.37 Million CNY | 102.87% |
| 2018 Q4 | 126.37 Million CNY | 8.57% |
| 2018 Q2 | 94.29 Million CNY | 26.07% |
| 2018 Q1 | 74.79 Million CNY | 20.06% |
| 2017 Q1 | 52.83 Million CNY | 7.72% |
| 2017 Q3 | 70.49 Million CNY | 32.93% |
| 2017 Q4 | 62.29 Million CNY | -11.64% |
| 2017 FY | 62.29 Million CNY | 26.99% |
| 2017 Q2 | 53.03 Million CNY | 0.36% |
| 2016 Q4 | 49.05 Million CNY | 0.0% |
| 2016 FY | 49.05 Million CNY | 24.59% |
| 2015 FY | 39.37 Million CNY | 95.06% |
| 2015 Q1 | 19.15 Million CNY | 0.0% |
| 2014 FY | 20.18 Million CNY | 44.66% |
| 2013 FY | 13.95 Million CNY | 19.27% |
| 2012 FY | 11.69 Million CNY | 0.0% |